🔎 Meet #ONCOSCREEN partner URIOJA 🇪🇸
The team will lead health economics analysis of the project’s trials, evaluating innovative screening solutions and exploring financial schemes that support collaboration between public and private healthcare.

🔎 Meet #ONCOSCREEN partner URIOJA 🇪🇸
The team will lead health economics analysis of the project’s trials, evaluating innovative screening solutions and exploring financial schemes that support collaboration between public and private healthcare.
How can research translate into game-changing innovation in clinical practice? 🔬
Join #ONCOSCREEN, #DIOPTRA , #SANGUINE, #LUCIA, #MammoScreen & #PANCAID at the Prevention & Early Detection Screening Cluster Open Day in Liège 🇧🇪 on 26 Nov.
📍 Register: ti.to/dioptra/eu-m...
Day 2 of the #ONCOSCREEN Plenary in Graz! 🇦🇹
Today we’re focusing on clinical trials, holistic evaluation and living guidelines, before closing with a policy workshop exploring the project’s potential impact on future EU policy for CRC screening & prevention. 📜
This afternoon #ONCOSCREEN, partners are focusing on advancing CRC diagnostics and developing intelligent tools for citizens, clinicians & policymakers.
We’ll also hold our 3rd Exploitation & IPR Workshop, exploring how we can create lasting impact beyond the project.
Guten Morgen aus Graz! 🇦🇹
The 3rd #ONCOSCREEN Plenary is underway at the Medical University of Graz.
After an insightful tour of the Institute of Pathology and Biobank, we’re getting into updates on technical management, evidence-based studies and end-user requirements.
Stay tuned for more!🔬